1. Home
  2. PRVA vs VERA Comparison

PRVA vs VERA Comparison

Compare PRVA & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Privia Health Group Inc.

PRVA

Privia Health Group Inc.

HOLD

Current Price

$24.75

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$35.25

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRVA
VERA
Founded
2007
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.2B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
PRVA
VERA
Price
$24.75
$35.25
Analyst Decision
Buy
Strong Buy
Analyst Count
12
10
Target Price
$31.17
$81.30
AVG Volume (30 Days)
718.7K
1.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
63.64
N/A
EPS
0.18
N/A
Revenue
$2,122,842,000.00
N/A
Revenue This Year
$18.19
N/A
Revenue Next Year
$10.72
$472.48
P/E Ratio
$138.06
N/A
Revenue Growth
22.26
N/A
52 Week Low
$18.78
$18.76
52 Week High
$26.51
$56.05

Technical Indicators

Market Signals
Indicator
PRVA
VERA
Relative Strength Index (RSI) 66.49 30.97
Support Level $22.63 $22.10
Resistance Level $25.23 $42.77
Average True Range (ATR) 0.73 1.88
MACD 0.13 -0.68
Stochastic Oscillator 81.98 5.44

Price Performance

Historical Comparison
PRVA
VERA

About PRVA Privia Health Group Inc.

Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: